CompanyDeals

Shuangcheng Pharma Licenses US Rights for Paclitaxel Injection to Meitheal

CompanyDrug

HEC Pharma Overturns Patent Decision Against Novartis’ Gilenya

CompanyDeals

Nerviano Medical Sciences Collaborates with Merck on PARP1 Inhibitor NMS-293

Company

Moderna’s CMO Expresses Eagerness to Bring mRNA Vaccines to China

CompanyDrug

Novartis Faces Setback in US Patent Battle Over Multiple Sclerosis Drug Gilenya

CompanyDeals

Sino Biopharmaceutical Licenses Lanifibranor for NASH Treatment from Inventiva

CompanyDrug

Hengrui Medicine’s Dexmedetomidine Nasal Spray Gains Priority Review

CompanyDeals

Menarini and OrigiMed Partner on Pan-Cancer Single-Cell Diagnostic Platform

CompanyDeals

Jenscare Scientific Set for IPO to Fund Structural Heart Disease Solutions

CompanyDeals

InnoCare Pharma’s IPO Raises $411M for Drug R&D and Platform Upgrade

CompanyDrug

Humanwell’s Generic Clobazam Approved for Lennox-Gastaut Syndrome in China

CompanyDeals

AIM Vaccine Plans IPO to Fund Vaccine R&D and Pipeline Expansion